Want to join the conversation?
James Schneider from Goldman Sachs asks about the overall headcount plans for the remainder of the year. $CTSH said utilization came down a little bit in 1Q16, which was intentional. Headcount additions will slow in 2H16 from 1H16, but the goal will be to keep utilization in the ballpark that it is currently at.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?